Unfortunately what I had feared has become a reality by now. We are receiving the sub 10c treatment that I was talking about and obviously the share price did not run away from us.
I am curious to have a look at the June quarterly cash flow report. Does anybody know how costs are being booked exactly? Are costs associated with operating the plant being booked as development costs as long as the company hasn't declared production "commercial"? If so this could explain why forecast production costs are zero while the company whithout a doubt is incurring costs associated with running the plant producing tungsten concentrate.
CNQ Price at posting:
9.9¢ Sentiment: Hold Disclosure: Held
